R&d Activities Boost Molecular Biology Kits & Reagents And Enzymes Market Growth

By Author: Pramod Kumar
Total Articles: 97
Comment this article

A number of factors, such as the rising cases of genetic illnesses, surging aging population, growing healthcare expenditure, increasing incidence of cancer and infectious diseases, and rising number of research and development (R&D) activities, are projected to boost the growth of the molecular biology kits & reagents and enzymes market at a CAGR of 17.2% in the forecast period (2016–2022). According to P&S Intelligence, the market generated revenue of $4,928.3 million in 2015.

Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/molecular-biology-kits-and-reagents-and-enzymes-market/report-sample

The molecular biology kits & reagents and enzymes market is witnessing the rising number of agreements, collaborations, and product launches by industry players in order to stay ahead of their competitors. For instance, New England Biolabs Inc. collaborated with AmpTec GmbH in October 2016. Under this agreement, the former will supply critical reagents to the latter for producing synthetic long ribonucleic acid (RNA) and messenger RNA (mRNA) for R&D, therapeutic, ...
... and diagnostic applications. This agreement has been helping New England Biolabs strengthen its position and become an important supplier to the RNA synthesis sector.

Make an Enquiry before Purchase: https://www.psmarketresearch.com/send-enquiry?enquiry-url=molecular-biology-kits-and-reagents-and-enzymes-market

Globally, North America is the largest market for molecular biology kits & reagents and enzymes. This is attributed to the increase in the number of R&D activities, rise in the cases of genetic ailments, and surge in the number of biotechnology and pharmaceutical companies in the region. On the other hand, the Asia-Pacific (APAC) market is projected to observe the highest CAGR, of 17.8%, during the forecast period. This can be ascribed to the growing awareness about these products and rising volume of molecular diagnoses in the region.

Thus, the rising incidence of cancer and infectious diseases and increasing R&D activities for unearthing better diagnostic and treatment methods are expected to propel the growth of the market during the forecast period.

Pramod has around 7 years of experience in market research and consulting services for healthcare industry. He holds varied experience in market sizing and forecasting with varied models, competition landscape, consumer behavior analysis, opportunity analysis, product/company benchmarking, data mining and others. He has successfully delivered multiple projects on go-to-market strategies, pricing strategy, price point analysis, Business Expansion, market entry and exit, share analysis and others. Prior to joining P&S Intelligence, he worked with different research companies, including Transparency Market Research and MarketsandMarkets Pvt Ltd. Some of the projects delivered by him include Scar Treatment Market, Skin Replacement and Substitutes Market, and Energy-Based Aesthetic Devices Market.